Analysis of Gut Microbiota Composition in Lung Adenocarcinoma Patients with TCM Qi-Yin Deficiency.


Journal

The American journal of Chinese medicine
ISSN: 1793-6853
Titre abrégé: Am J Chin Med
Pays: Singapore
ID NLM: 7901431

Informations de publication

Date de publication:
2021
Historique:
pubmed: 8 9 2021
medline: 15 12 2021
entrez: 7 9 2021
Statut: ppublish

Résumé

In Lung adenocarcinoma (ADC), Qi-Yin deficiency syndrome (QY) is the most common Traditional Chinese medicine (TCM) syndrome. This study aimed to investigate the diversity and composition of gut microbiota in ADC patients with QY syndrome. 90 stool samples, including 30 healthy individuals (H), 30 ADC patients with QY syndrome, and 30 ADC patients with another syndrome (O) were collected. Then, 16s-RNA sequencing was used to analyze stool samples to clarify the structure of gut microbiota, and linear discriminant analysis (LDA) effect size (LEfSe) was applied to identify biomarkers for ADC with QY syndrome. Logistic regression analysis was performed to establish a diagnostic model for the diagnosis of QY syndrome in ADC patients, which was assessed with the AUC. Finally, 20 fecal samples (QY: 10; O: 10) were analyzed with Metagenomics to validate the diagnostic model. The [Formula: see text] diversity and [Formula: see text] diversity demonstrated that the structure of gut microbiota in the QY group was different from that of the H group and O group. In the QY group, the top 3 taxonomies at phylum level were Firmicutes, Bacteroidetes, and Proteobacteria, and at genus level were Faecalibacterium, Prevotella_9, and Bifidobacterium. LEfSe identified Prevotella_9 and Streptococcus might be the biomarkers for QY syndrome. A diagnostic model was constructed using those 2 genera with the AUC = 0.801, similar to the AUC based on Metagenomics (0.842). The structure of gut microbiota in ADC patients with QY syndrome was investigated, and a diagnostic model was developed for the diagnosis of QY syndrome in ADC patients, which provides a novel idea for the understanding and diagnosis of TCM syndrome.

Identifiants

pubmed: 34488552
doi: 10.1142/S0192415X21500786
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1667-1682

Auteurs

Jiabin Chen (J)

Department of Oncology, Tongde Hospital of Zhejiang, Hangzhou, Zhejiang 310012, P. R. China.

Sheng Wang (S)

Department of Respiratory, Jinhua Guangfu Hospital, Jinhua, Zhejiang 321000, P. R. China.

Jianfei Shen (J)

Department of Thoracic Surgery, Taizhou Hospital, Taizhou, Zhejiang 310012, P. R. China.

Qinqin Hu (Q)

Department of Oncology, Tongde Hospital of Zhejiang, Hangzhou, Zhejiang 310012, P. R. China.

Yongjun Zhang (Y)

Cancer Hospital of University of Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, P. R. China.

Dehua Ma (D)

Department of Thoracic Surgery, Taizhou Hospital, Taizhou, Zhejiang 310012, P. R. China.

Kequn Chai (K)

Department of Oncology, Tongde Hospital of Zhejiang, Hangzhou, Zhejiang 310012, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH